BRAVO esophageal pH monitoring measures acid exposure in the esophagus over several days using a small capsule placed during a sedated endoscopy. The capsule transmits data to a wearable recorder while you go about normal activities. The results help your provider understand reflux patterns and guide treatment decisions.
Let your doctor know if you have an implanted electronic device such as a pacemaker or implantable cardiac defibrillator (ICD), a history of bleeding problems, dilated blood vessels, a nickel allergy, or any other previously known problems with your esophagus.
If you have diabetes or are taking medications for weight loss, use the following instructions:
Preparation involves medication planning and fasting before capsule placement, followed by several days of monitoring. You’ll wear the recorder, track symptoms in a diary, and return the equipment after the study is complete. Detailed instructions and exact timing are provided below.
If you take GLP-1 medications (Ozempic (Semaglutide), Mounjaro (Trizepatide) or ANY GLP-1) - DO NOT TAKE 7-DAYS PRIOR TO YOUR PROCEDURE
If you take SGLT2 medications (Jardiance, Farxiga, Invokana, Steglatro, Brenzavvy, Glyxambi, Synjardy, Xigduo, Qtern) - DO NOT TAKE 3 DAYS PRIOR TO YOUR PROCEDURE. If you are taking any of these medications, use the following instructions.
THE DAY BEFORE YOUR PROCEDURE
THE DAY OF YOUR PROCEDURE
THE DAY OF YOUR PROCEDURE
Si su seguro exige una remisión o una autorización previa, nuestra oficina de facturación hará todo lo posible por obtenerla antes de que se presten los servicios. Si decide continuar sin la autorización requerida, es posible que el seguro deniegue la cobertura. Si es usted un paciente de Medicare, es posible que se le pida que firme un Aviso Previo al Beneficiario (ABN) en el que reconozca su responsabilidad financiera en caso de que el seguro no pague. Si está afiliado a un plan de seguro privado, se le pedirá que firme un formulario de servicios no cubiertos.